Trials / Completed
CompletedNCT04829149
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
A Cohort Study for Comparison of Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration and Statin Prescription Patterns in Patients With Dyslipidemia in Korea.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,717 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Cohort Study for Comparison of Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration and Statin Prescription Patterns in Patients With Dyslipidemia in Korea.
Detailed description
The main objective of this study is to evaluate the effect of reducing LDL-C levels after 12 months of administration of Statin Monotherapy or Rosuzet Tab.(Rosuvastatin/Ezetimibe) in patients with dyslipidemia in Korea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational | Statin therapy group and Rosuzet tablet group |
Timeline
- Start date
- 2016-06-14
- Primary completion
- 2019-06-01
- Completion
- 2019-08-29
- First posted
- 2021-04-02
- Last updated
- 2021-04-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04829149. Inclusion in this directory is not an endorsement.